fotemustine has been researched along with Cancer of Liver in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (32.14) | 18.2507 |
| 2000's | 10 (35.71) | 29.6817 |
| 2010's | 7 (25.00) | 24.3611 |
| 2020's | 2 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Bruckner, E; Kővári, B; Langner, C; Lauwers, GY; Varelas, AI | 1 |
| Bauer, S; Haubold, J; Ludwig, JM; Richly, H; Schaarschmidt, BM; Siveke, JT; Theysohn, JM; Umutlu, L; Wimmer, J | 1 |
| Bedane, C; Combemale, P; Cupissol, D; Derrey, S; Dygai-Cochet, I; Lamant, L; Leccia, MT; Lubrano, V; Mazeau-Woynar, V; Mirabel, X; Modiano, P; Mourrégot, A; Planchamp, F; Rougé Bugat, ME; Sassolas, B; Siegrist, S; Thariat, J; Tiffet, O; Truc, G; Verdoni, L | 1 |
| Baurain, JF; Durando, X; Gurunath, RK; Jouary, T; Kaempgen, E; Keilholz, U; Leyvraz, S; Marshall, E; Negrier, S; Piperno-Neumann, S; Schadendorf, D; Scheulen, M; Suciu, S; Testori, A; Vermorken, JB; Zdzienicki, M | 1 |
| Aigner, B; Artl, M; Niederkorn, A; Richtig, E; Schwantzer, G; Wackernagel, W | 1 |
| Chi, ZH; Cui, CL; Guo, J; Lian, HY; Si, L; Yuan, XQ | 1 |
| Bechrakis, N; Foerster, MH; Keilholz, U; Krössin, M; Lindner, M; Schmittel, A; Schuster, R; Thiel, E; Wacker, F | 1 |
| Amadori, D; Calzolari, F; Farolfi, A; Guidoboni, M; Milandri, C; Ridolfi, L; Ridolfi, R; Scarpi, E | 1 |
| Arcoria, D; Calì, S; DI Maggio, EM; Ferraù, F; Malaponte, E; Panebianco, V; Parisi, A; Romeo, P; Vasta, F; Vitale, FV | 1 |
| Beitzke, D; Berzaczy, D; Edelhauser, G; Funovics, M; Höeller, C; Lammer, J; Schicher, N | 1 |
| Becker, JC; Bröcker, EB; Kämpgen, E; Lieb, W; Neumann, C; Schadendorf, D; Steinmann, A; Terheyden, P; Wagner, S; Wittenberg, G | 1 |
| Eigentler, TK; Garbe, C | 1 |
| Grange, JD; Kodjikian, L; Rivoire, M | 1 |
| Bosshard, W; Fiorentini, G; Gillet, M; Humblet, Y; Keilholz, U; Leyvraz, S; Lotem, M; Pampallona, S; Peters, S; Piperno-Neumann, S; Popescu, R; Stupp, R; Voelter, V; Weitzen, R; Zografos, L | 1 |
| Bembenek, A; Hauschild, A; Kähler, KC; Kettelhack, C; Schlag, PM; Siegel, R | 1 |
| Bessoud, B; De Baere, T; Denys, A; Doenz, F; Proietti, S; Qanadli, SD; Schnyder, P | 1 |
| Denys, A; Goitein, G; Halkic, N; Leyvraz, S; Pampallona, S; Peters, S; Schalenbourg, A; Voelter, V; Zografos, L | 1 |
| Boaziz, C; Breau, JL; Israël, L; Mazeron, JJ; Morere, JF | 1 |
| Chaitchik, S; Merimsky, O | 1 |
| Bauer, J; Dorval, T; Gillet, M; Lejeune, F; Leyvraz, S; Meuli, R; Pampallona, S; Salmon, R; Spataro, V; Zografos, L | 1 |
| Asselain, B; Desjardins, L; Dorval, T; Levy, C; Leyvraz, S; Plancher, C; Pouillart, P; Salmon, RJ; Schlienger, P; Servois, V | 1 |
| Casella, G; di Bonito, M; Fortuna, G; Iodice, F; Stellato, G; Tramontana, R; Tramontana, S | 1 |
| Bokemeyer, C; Fety, R; Giroux, B; Hartmann, JT; Lucas, C; Schmoll, E; Schmoll, HJ | 1 |
| Bock, M; Deichmann, M; Jäckel, A; Näher, H; Waldmann, V | 1 |
| Egerer, G; Ho, AD; Keilholz, U; Lehnert, T; Max, R; Naeher, H | 1 |
| Boaziz, C | 1 |
| Cour, V; Fety, R; Lucas, C; Solere, P; Vignoud, J | 1 |
| Aigner, K; Auclerc, G; Bizzari, JP; Borel, C; Bousquet, JC; Buthiau, D; Cohen-Alloro, G; Cour, V; Khayat, D; Weil, M | 1 |
5 review(s) available for fotemustine and Cancer of Liver
| Article | Year |
|---|---|
[Therapy of malignant melanoma at the stage of distant metastasis].
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dacarbazine; Disease Progression; Humans; Immunotherapy; Interferon-alpha; Interleukin-2; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Melanoma; Neoplasm Metastasis; Nitrosourea Compounds; Organophosphorus Compounds; Palliative Care; Prognosis; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Skin Neoplasms; Temozolomide; Time Factors; Tomography, X-Ray Computed; Vindesine | 2004 |
[Malignant melanoma of the uvea].
Topics: Antineoplastic Agents; Brachytherapy; Combined Modality Therapy; Eye Enucleation; Female; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Melanoma; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Uveal Neoplasms | 1993 |
[Therapy of metastatic malignant uveal melanoma].
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemoembolization, Therapeutic; Female; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Male; Melanoma; Middle Aged; Multicenter Studies as Topic; Neoplasm Metastasis; Nitrosourea Compounds; Organophosphorus Compounds; Prognosis; Skin Neoplasms; Time Factors; Uveal Neoplasms | 2001 |
[Contribution of a new nitrosourea compound: fotemustine].
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dacarbazine; Drug Therapy, Combination; Humans; Liver Neoplasms; Lung Neoplasms; Melanoma; Nitrosourea Compounds; Organophosphorus Compounds | 1992 |
Fotemustine (S 10036) in the intra-arterial treatment of liver metastasis from malignant melanoma. A phase II Study.
Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Drug Evaluation; Female; Hematologic Diseases; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Melanoma; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Pilot Projects; Remission Induction | 1991 |
9 trial(s) available for fotemustine and Cancer of Liver
| Article | Year |
|---|---|
Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial.
Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Disease-Free Survival; Female; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver; Liver Neoplasms; Male; Melanoma; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Prospective Studies; Survival Analysis; Uveal Neoplasms; Young Adult | 2014 |
[Hepatic intra-arterial bio-chemotherapy for the treatment of melanoma patients with liver metastasis: a phase II clinical study].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytokine-Induced Killer Cells; Dacarbazine; Disease-Free Survival; Female; Follow-Up Studies; Granulocyte-Macrophage Colony-Stimulating Factor; Hepatic Artery; Humans; Immunotherapy, Adoptive; Infusions, Intra-Arterial; Interleukin-2; Liver Neoplasms; Male; Melanoma; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Recombinant Proteins; Remission Induction; Survival Rate; Thrombocytopenia; Young Adult | 2008 |
Treatment of disseminated ocular melanoma with sequential fotemustine, interferon alpha, and interleukin 2.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoembolization, Therapeutic; Combined Modality Therapy; Female; Hepatic Artery; Humans; Immunotherapy; Infusions, Intra-Arterial; Interferon-alpha; Interleukin-2; Liver Neoplasms; Male; Melanoma; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Prospective Studies; Survival Rate; Treatment Outcome; Uveal Neoplasms | 2002 |
Hepatic arterial Fotemustine chemotherapy in patients with liver metastases from cutaneous melanoma is as effective as in ocular melanoma.
Topics: Adult; Aged; Antineoplastic Agents; Eye Neoplasms; Female; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Melanoma; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Skin Neoplasms; Survival Analysis | 2007 |
Adjuvant intra-arterial hepatic fotemustine for high-risk uveal melanoma patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Melanoma; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Risk; Secondary Prevention; Survival Analysis; Uveal Neoplasms | 2008 |
Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Catheters, Indwelling; Eye Neoplasms; Female; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Melanoma; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Prospective Studies; Survival Analysis; Treatment Outcome | 1997 |
Phase I pharmacological study of intra-arterially infused fotemustine for colorectal liver metastases.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Colorectal Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds | 1998 |
Pilot study of hepatic intraarterial fotemustine chemotherapy for liver metastases from uveal melanoma: a single-center experience with seven patients.
Topics: Adult; Antineoplastic Agents; Female; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Melanoma; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Survival Analysis; Treatment Outcome; Uveal Neoplasms | 2001 |
Fotemustine (S 10036) in the intra-arterial treatment of liver metastasis from malignant melanoma. A phase II Study.
Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Drug Evaluation; Female; Hematologic Diseases; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Melanoma; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Pilot Projects; Remission Induction | 1991 |
15 other study(ies) available for fotemustine and Cancer of Liver
| Article | Year |
|---|---|
Metachronous double-hit by transarterial chemoembolisation (TACE) with fotemustine inducing dysplasia-like atypia in the gallbladder and stomach-A diagnostic pitfall.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Gallbladder; Humans; Liver Neoplasms; Nitrosourea Compounds; Organophosphorus Compounds; Stomach; Treatment Outcome | 2022 |
Predictive impact of the inflammation-based indices in uveal melanoma liver metastases treated with transarterial hepatic chemoperfusion.
Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Antineoplastic Agents; Aspartate Aminotransferases; Biomarkers, Tumor; Blood Platelets; C-Reactive Protein; Chemotherapy, Cancer, Regional Perfusion; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Lymphocytes; Male; Melanoma; Melphalan; Middle Aged; Neutrophils; Nitrosourea Compounds; Organophosphorus Compounds; Prognosis; Proportional Hazards Models; Retrospective Studies; Tumor Burden; Uveal Neoplasms | 2021 |
[Management of patients with metastatic cutaneous melanoma: French national guidelines. French National Cancer Institute].
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Bone Neoplasms; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Disease Management; France; Humans; Indoles; Ipilimumab; Liver Neoplasms; Lung Neoplasms; Melanoma; Molecular Targeted Therapy; Neoplasm Staging; Nitrosourea Compounds; Oncogenes; Organophosphorus Compounds; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Sulfonamides; Temozolomide; Vemurafenib | 2014 |
Response of patients with metastatic uveal melanoma to combined treatment with fotemustine and sorafenib.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Niacinamide; Nitrosourea Compounds; Organophosphorus Compounds; Phenylurea Compounds; Retrospective Studies; Sorafenib; Survival Rate; Uveal Neoplasms | 2014 |
Transarterial chemoembolization of liver metastases from uveal melanoma after failure of systemic therapy: toxicity and outcome.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Chemoembolization, Therapeutic; Cisplatin; Disease-Free Survival; Female; Humans; Liver Neoplasms; Male; Melanoma; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Randomized Controlled Trials as Topic; Remission Induction; Treatment Outcome; Uveal Neoplasms | 2010 |
Liver metastases from melanoma: hepatic intra-arterial chemotherapy. A retrospective study.
Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Drug Delivery Systems; Drug Monitoring; Electronic Health Records; Female; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Melanoma; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Retrospective Studies; Survival Analysis; Uveal Neoplasms; Young Adult | 2011 |
Initial experience with hepatic intraarterial fotemustine and interferon alpha 2b combination for treatment of liver tumors.
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Female; Humans; Infusions, Intra-Arterial; Interferon alpha-2; Interferon-alpha; Liver; Liver Neoplasms; Male; Medical Oncology; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Recombinant Proteins; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Fotemustine chemoembolization of hepatic metastases from uveal melanoma: a retrospective single-center analysis.
Topics: Adult; Aged; Antineoplastic Agents; Chemoembolization, Therapeutic; Contrast Media; Ethiodized Oil; Female; Humans; Liver Neoplasms; Male; Melanoma; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Proportional Hazards Models; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Uveal Neoplasms | 2012 |
Prolonged survival after resection of liver metastases from uveal melanoma and intra-arterial chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Dacarbazine; Fatal Outcome; Female; Follow-Up Studies; Hepatectomy; Humans; Injections, Intra-Arterial; Liver Neoplasms; Melanoma; Neoplasm Metastasis; Nitrosourea Compounds; Organophosphorus Compounds; Survival Rate; Time Factors; Uveal Neoplasms | 2005 |
Intra-arterial hepatic fotemustine for the treatment of liver metastases from uveal melanoma: experience in 101 patients.
Topics: Adult; Aged; Antineoplastic Agents; Female; Humans; Injections, Intra-Arterial; Liver Neoplasms; Male; Melanoma; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Uveal Neoplasms | 2006 |
Interventional management of gastroduodenal lesions complicating intra-arterial hepatic chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Duodenal Ulcer; Duodenum; Embolization, Therapeutic; Endoscopy, Gastrointestinal; Female; Femoral Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Nitrosourea Compounds; Organophosphorus Compounds; Organoplatinum Compounds; Oxaliplatin; Stomach; Stomach Ulcer; Treatment Outcome | 2007 |
Fotemustine-dacarbazine combinations in the treatment of metastatic melanoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Humans; Liver Neoplasms; Lung Neoplasms; Melanoma; Nitrosourea Compounds; Organophosphorus Compounds | 1993 |
Treatment of liver metastases from uveal melanoma by combined surgery-chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Catheters, Indwelling; Chemotherapy, Adjuvant; Cisplatin; Female; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Melanoma; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Prospective Studies; Survival Analysis; Treatment Outcome; Uveal Neoplasms | 1998 |
Primary malignant melanoma of the vagina: case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Dacarbazine; Female; Follow-Up Studies; Humans; Interferon alpha-2; Interferon-alpha; Liver Neoplasms; Lymph Node Excision; Melanoma; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Recombinant Proteins; Vaginal Neoplasms | 1998 |
Hepatic intra-arterial infusion of fotemustine: pharmacokinetics.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Colorectal Neoplasms; Female; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Leukopenia; Liver Neoplasms; Male; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Thrombocytopenia | 1992 |